Preview

Operations Management Exam Revision

Good Essays
Open Document
Open Document
15042 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Operations Management Exam Revision
Department of Decision Sciences

San Francisco State University

FINAL EXAM QUESTIONS
The sample problems below are organized by topic. Where possible, answers are given.
Disclaimers:
• These questions are questions that have appeared on previous years’ (final) examinations.
They are for practice only. There is no guarantee that the questions on your finals will be the same, or that different professors will give the same types of questions.
• Not all 412/786 sections cover the same material. The questions may contain material that is unfamiliar to you, or not contain material you covered. If you have concerns about the topics for your final, talk to your professor.
• Short answer and multiple choice questions are not included in this handout.
• Some questions may have been slightly modified to make them more general.

Decision Analysis
1. Sheree is deciding on how to invest her $1000 tax refund. She reads that Merck is partnering with a small biotech firm to produce a cancer drug which may or may not receive FDA approval in the next six months. If the FDA approves it, the biotech firm’s stock will double in value, but if it rejects it, the firm goes bankrupt and its stock becomes worthless. Merck is a huge pharmaceutical, so approval will result in a 20% appreciation in stock, and rejection in a 10% decrease. She is also considering hedging her bets and investing half her money in Merck and half in the Biotech firm. She could also put her money in a safe mutual fund, with a small (but guaranteed) 3% increase in value in the next six months.
a) Fill in the decision table, labeling all decisions, outcomes and payoffs. Express payoffs in terms of expected portfolio value at the end of six months. Hint: the table has the correct dimensions.
Outcomes
___________
Decisions

_____________

___________
___________
___________
_______

b) Given the payoff table what is Sheree’s best decision using the Laplace, Maximax, and
Maximin

You May Also Find These Documents Helpful

  • Satisfactory Essays

    Trueblood Case 09 2

    • 804 Words
    • 2 Pages

    Company XYZ is an unrelated third-party private equity investor with no prior relationship or business operations related to Pharmagen…

    • 804 Words
    • 2 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Cetuximab Case Study

    • 316 Words
    • 2 Pages

    Generally, patent biologics are in the cleft of expiration and there are a rise in the demand for biosimilar. Our company will start to develop biosimilar for Cetuximab (Erbitux), which is an epidermal growth factor receptor (EGFR) inhibitor. Eli Lilly produces the drug in the U.S and Canada market whereas Merm KGaA produced Cetuximab for territory outside the USA and Canada. We want to pursue a biosimilar for Cetuximab to build a brand image and find finance to move to our main focus, which is biosimilar for Blinatumomab. Blinatumomab (Blincyto) is a bifunctional antibody that used to treat Philadelphia chromosome-negative refractory acute lymphoblastic leukemia. Blinatumomab approved in December 2014 by the US Food and Drug Administration under the accelerated approval program.…

    • 316 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    The team viewed the video “Cost of Capital” as part of our weekly team discussion. In the video, Amil Singh discussed the cost of capital for Pfizer Inc. Pfizer Inc. is the world 's largest research-based pharmaceutical company that develops its own products in America. Pfizer revenue is about $65 billion with market gap close to $140 billion (John Wiley and Sons, 2012). The cost of capital is the "rate of return that capital could expect to earn in an alternative investment of equivalent risk" (Investopedia LLC, 2015). When the company researches and develops a new product it can take nearly eight to ten years before it hits the market and see a profit. In this paper, we will look at how Pfizer addresses its cost of capital and issues with research and development.…

    • 865 Words
    • 3 Pages
    Good Essays
  • Powerful Essays

    Acc 4291 Case Study

    • 4922 Words
    • 20 Pages

    The case study mainly discussed on the City of Yorba Linda, California. The case overview…

    • 4922 Words
    • 20 Pages
    Powerful Essays
  • Better Essays

    Merck Kl798 Case

    • 920 Words
    • 4 Pages

    Based on the decision tree model, it is recommended that Pat Harlow does not invest in the purchase of KL-798 from Kappa Labs assuming that the current payoffs and expected probabilities given currently are correct and do not change in the future. At the current decision point, during Phase I tests, there is an expected payoff of -$1.16 million based on the probabilities of success further in the future and expected returns. If Merck can negotiate either the price of KL-798 down by more than $1.16 million or reduce their contribution to complete Phase I testing, this could be an attractive option to invest in.…

    • 920 Words
    • 4 Pages
    Better Essays
  • Satisfactory Essays

    Five of the following seven questions will be on the final exam. From the five on the exam you will pick two to write on using material from lectures and the text book. Be as thorough and detailed as possible.…

    • 415 Words
    • 2 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Find an option that would be best suited for Pharma to meet current and future demand.…

    • 717 Words
    • 3 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Amgen’s Epogen

    • 541 Words
    • 3 Pages

    They will be able to get to market without any legal problems and start bringing in revenue. This will stabilize Amgen’s stock price…

    • 541 Words
    • 3 Pages
    Satisfactory Essays
  • Powerful Essays

    Merck/Medco Case Analysis

    • 3129 Words
    • 13 Pages

    acquisition of Medco represents a $6.6 billion bet on where the future of the pharmaceutical…

    • 3129 Words
    • 13 Pages
    Powerful Essays
  • Good Essays

    Beta Management

    • 1150 Words
    • 5 Pages

    Ms. Wolfe felt that now was the right time to begin her program of adding individual stock investments and increasing her equity position. A $200,000 purchase of one of these stocks would increase her total equity exposure to $20 million…

    • 1150 Words
    • 5 Pages
    Good Essays
  • Good Essays

    Answer: Capacity is the maximum rate of output of a process or a system. And utilization is measured as the ratio of average output rate to maximum capacity. In Southwest, capacity can be measured in available seat-miles (AMS) pre month. Therefore, utilization can be measured as the ratio of average seat-mile rate to maximum seat-miles.…

    • 1717 Words
    • 7 Pages
    Good Essays
  • Good Essays

    Ginny's Restaurant Case

    • 575 Words
    • 3 Pages

    Virginia’s optimal investment in the restaurant is $3 million, which give her a total of $5,150,943 at the end of year 1. This is approximately a 29% increase in her wealth.…

    • 575 Words
    • 3 Pages
    Good Essays
  • Powerful Essays

    While awaiting Phase 3 approval, Biocon can roll out its direct sales force, offering its suite of generic oncology drugs. This waiting…

    • 2718 Words
    • 7 Pages
    Powerful Essays
  • Satisfactory Essays

    Barbera Arneson Case

    • 437 Words
    • 2 Pages

    a) If InterWeb goes IPO at $10/share her stock will gain $594,000 b) If InterWeb goes IPO at the typical $12.50/share her gain will be $744,000 c) If INterweb goes IPO at $15/share then her return will be $894,000…

    • 437 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    Marketing and Phase Trial

    • 1171 Words
    • 5 Pages

    Sensing the arrival of Erbitux into the Indian market some of members of Biocon management wanted a fast launch of BioMab. Cancer is a very critical illness and any deficiency in the medicine can be fatal for individuals. So ideally Biocon should first go for 3rd phase trial, check the competency of the product and then go for launch. They should not look for a short term advantage of being first entrant. Since of their product face any rejection (or have any drawback), it can be devastating on the reputation of the company. This can dampen the company’s image which can badly go against them.…

    • 1171 Words
    • 5 Pages
    Good Essays